0.655
3.61%
-0.0245
Pre-mercato:
.7237
0.0687
+10.49%
Mira Pharmaceuticals Inc Borsa (MIRA) Ultime notizie
Q3 2024 Earnings Estimate for Quipt Home Medical Corp. Issued By Echelon Wealth Partners (NASDAQ:QIPT) - Defense World
Defense World
NantHealth (NASDAQ:NH) Now Covered by StockNews.com - Defense World
Defense World
NantHealth (NASDAQ:NH) Now Covered by StockNews.com - Defense World
Defense World
PRA Group (NASDAQ:PRAA) Rating Lowered to Hold at StockNews.com - Defense World
Defense World
MIRA Pharmaceuticals, Inc. Expected to Post FY2026 Earnings of ($0.39) Per Share (NASDAQ:MIRA) - Defense World
Defense World
Perpetua Resources Corp. (NASDAQ:PPTA) Expected to Earn FY2024 Earnings of ($0.20) Per Share - Defense World
Defense World
Confluent, Inc. (NASDAQ:CFLT) Stake Lessened by Amalgamated Bank - Defense World
Defense World
Mira Pharmaceuticals reports progress on depression treatment By Investing.com - Investing.com
Investing.com
Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket
Benzinga
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - InvestorPlace
InvestorPlace
MIRA Pharmaceuticals Board Revamp and Strategic Advisory Hire - TipRanks.com - TipRanks
TipRanks
Baker Hill Nominated for Tech Company of the Year in TechPoint's 25th Annual Mira Awards - PR Newswire
PR Newswire
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace
InvestorPlace
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Why Porch Group Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Is AerSale (ASLE) Stock Down 18% Today? - InvestorPlace
InvestorPlace
What's Driving Organon & Co's Surprising 43% Stock Rally? - GuruFocus.com
GuruFocus.com
Is MIRA Pharmaceuticals (NASDAQ:MIRA) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Yahoo Finance
Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Mo - Benzinga
Benzinga
Insiders Could Have Profited By Holding onto MIRA Pharmaceuticals Shares Despite 12% Drop - Simply Wall St
Simply Wall St
Biopharma IPO class of 2023 ends the year with performance up 7% - BioWorld Online
BioWorld Online
Matthew Perry's ketamine OD prompts questions about its use for mental illness - Bradford Era
Bradford Era
Thinking about buying stock in Macy's, Bitfarms, Nio Inc, Li Auto, or Mira Pharmaceuticals? - PR Newswire
PR Newswire
Abbott baby formula aftermath: One dead child and another with brain damage so bad she has constant seizures and ... - Fortune
Fortune
Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid ... - Markets Insider
Markets Insider
Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid ... - Markets Insider
Markets Insider
MIRA, MIRALOGX sign agreement for depression therapy - Pharmaceutical Technology
Pharmaceutical Technology
Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
What's Going On With Aurinia Pharmaceuticals Stock? - Markets Insider
Markets Insider
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com India
Investing.com India
Mirati Therapeutics Receives Approval from the MHRA for KRAZATI (adagrasib) as a Targeted Treatment Option for ... - PR Newswire
PR Newswire
Baltimore pharmaceutical company faces delisting from the Nasdaq - Baltimore Business Journal - The Business Journals
The Business Journals
Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal - Reuters
Reuters
Sanofi weighs Mirati buy as KRAS cancer drug battle enters new phase: Bloomberg - FiercePharma
FiercePharma
Viatris and Ocuphire Pharma Announce FDA Approval of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% Eye ... - PR Newswire
PR Newswire
Why Biophytis Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket - Avalo Therap - Benzinga
Benzinga
MIRA Pharmaceuticals to Host Virtual Roadshow Webinar on Monday, September 11, 2023 at 1:00 p.m. Eastern Time - Barchart
Barchart
IPOs take August off - BioCentury
BioCentury
Viking to Benefit From Biopharma IPO - Institutional Investor
Institutional Investor
A Drug Being Developed to Treat Anxiety and Cognitive Decline in the Elderly - Nasdaq
Nasdaq
Mira Pharmaceuticals' IPO Fetches $9M, But Filings Spawn More Questions - Green Market Report
Green Market Report
MIRA Pharmaceuticals Set to Disrupt Cannabis and Pharma Markets with Nasdaq IPO - mg Magazine
mg Magazine
Following the legalization of recreational cannabis, MIRA Pharmaceuticals moves to go public - Technical.ly
Technical.ly
Apple acquires Mira, a startup building lightweight AR hardware - TechCrunch
TechCrunch
The need for access to anti-TB drugs in India: An interview with Anand Grover - The Leaflet
The Leaflet
Johns Hopkins University Researchers Find CBD May Increase the Adverse Effects of THC in Edible Cannabis Products - India Education Diary
India Education Diary
CBD May Increase the Adverse Effects of THC in Edible Cannabis Products, Study Shows - Johns Hopkins Medicine
Johns Hopkins Medicine
Capitalizzazione:
|
Volume (24 ore):